Profile
Einat Brill-Almon worked as Director of Research & Development at Medgenics Medical (Israel) Ltd.
from 2001 to 2004.
She then worked at Protalix Biotherapeutics, Inc. from 2004 to 2022, where she held the position of Senior Vice President & Chief Development Officer from 2020 to 2022.
Prior to that, she was Senior Vice President of Product Development at Protalix Ltd.
Dr. Brill-Almon received her undergraduate degree from The Hebrew University of Jerusalem and her graduate and doctorate degrees from the Weizmann Institute of Science.
Former positions of Einat Brill-Almon
| Companies | Position | End |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 2022-03-31 |
Medgenics Medical (Israel) Ltd.
 Medgenics Medical (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Medgenics Medical Israel Ltd. develops protein delivery technology. The company is headquartered in Misgav, Israel. | Chief Tech/Sci/R&D Officer | 2003-12-31 |
| Protalix Ltd. | Corporate Officer/Principal | - |
Training of Einat Brill-Almon
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Medgenics Medical (Israel) Ltd.
Medgenics Medical (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Medgenics Medical Israel Ltd. develops protein delivery technology. The company is headquartered in Misgav, Israel. | Commercial Services |
| Protalix Ltd. |
- Stock Market
- Insiders
- Einat Brill-Almon
